MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) for Prevention of Acute Respiratory Distress Syndrome in Patients with COVID-19

    NEXT STORY
    BeiGene Announces Appointment of Angus Grant as Chief Business Executive
    PREV STORY
    Global Therapeutic Vaccines Market By Type, By Product, By Technology, By Delivery Mechanism, By End User, By Region, Forecast & Opportunities, 2025
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Generex Signs Contract with EpiVax to Develop Ii-Key Peptide Vaccines to Address the Coronavirus Pandemic

    author_avatar
    NASDAQ Market News

    American College of Rheumatology Encourages Safe Adoption of Biosimilars During FDA Public Hearing on CT-P13, a Proposed Biosimilar for Infliximab (Remicade)

    ATLANTA, Feb. 10, 2016 (GLOBE NEWSWIRE) -- During a public meeting held Tuesday by ...

    author_avatar
    NASDAQ Market News

    Taconic Biosciences Launches Rapid Restart™ Program

    author_avatar
    NASDAQ Market News